CSCs were shown to recruit TAMs at the tumor site through the release of soluble factors such as periostin (POSTN) in GBM [109] and the activation of specific pathways such as the Hippo one in liver cancer models [110]. The gene discussed is POSTN; the disease is neoplasm.